Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mesoblast Limited - American Depositary Shares
(NQ:
MESO
)
15.37
+1.05 (+7.33%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mesoblast Limited - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
August 07, 2023
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...
Via
Benzinga
Why Shares of Mesoblast Are Down Monday
↗
August 07, 2023
The company's shares continued to tumble after it received a Complete Response Letter last week from the FDA.
Via
The Motley Fool
Why Shares of Mesoblast Are Plunging Friday
↗
August 04, 2023
The company received a Complete Response Letter from the FDA regarding its prospective graft-versus-host disease therapy.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
↗
August 07, 2023
Via
Benzinga
Dow Turns Lower; Amazon Shares Jump After Strong Q2 Results
↗
August 04, 2023
U.S. stocks pared gains toward the end of trading, with the Dow Jones and S&P 500 turning lower on Friday. The Dow traded down 0.08% to 35,187.47 while the NASDAQ rose 0.18% to 13,984.31. The S&P 500,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 04, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
August 04, 2023
On Friday, 73 companies reached new 52-week lows.
Via
Benzinga
Nasdaq Surges Over 100 Points; Apple Shares Fall After Q3 Results
↗
August 04, 2023
U.S. stocks were higher midway through trading, with the Nasdaq Composite gaining over 100 points on Friday. The Dow traded up 0.50% to 35,390.90 while the NASDAQ rose 0.81% to 14,072.42. The S&P 500,...
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
↗
August 04, 2023
Via
Benzinga
Nikola's Abrupt CEO Transition, Carl Icahn Led Icahn Enterprises Cuts Dividend Payout, FDA Rejects Mesoblast's Cell Therapy For Kids: Today's Top Stories
↗
August 04, 2023
Wall Street Journal
Via
Benzinga
Dow Jumps Over 100 Points; US Nonfarm Payrolls Miss Expectations
↗
August 04, 2023
U.S. stocks were higher this morning, following the release of jobs data. Following the market opening Friday, the Dow traded up 0.39% to 35,351.48 while the NASDAQ rose 0.79% to 14,070.50. The S&P...
Via
Benzinga
Mesoblast Shares Tumble As FDA Strikes Out Cell Therapy Application For Children Again, Requires Additional Trial
↗
August 04, 2023
The FDA issued a complete response letter to Mesoblast Limited's (NASDAQ: MESO) resubmission for remestemcel-L for pediatric steroid-refractory acute graft
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 28, 2023
Via
Benzinga
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion
↗
July 27, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 18, 2023
Via
Benzinga
Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday
↗
July 13, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) gained 18% to...
Via
Benzinga
WD-40, Shutterstock And Other Big Stocks Moving Higher On Tuesday
↗
July 11, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Hesai Group (NASDAQ: HSAI) rose 14.4% to $12.34.
Via
Benzinga
BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
↗
July 06, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumb
Via
Benzinga
William Blair Initiates Mesoblast Soon After Its Lead Product Goes Under FDA Review In Pediatric Indication
↗
March 09, 2023
Via
Benzinga
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
March 08, 2023
Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 08, 2023
Via
Benzinga
Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday
↗
March 08, 2023
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 30 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids
↗
March 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
March 08, 2023
Via
Benzinga
Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
↗
March 08, 2023
Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed topline results from single and multiple ascending dose parts of Phase 1...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
March 08, 2023
We're getting into the biggest pre-market stock movers traders will want to keep an eye on Wednesday with the latest news!
Via
InvestorPlace
Dow Dips 300 Points; Snap Shares Plunge
↗
February 01, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today